Psychological comorbidity increases the risk for postinfectious IBS partly by enhanced susceptibility to develop infectious gastroenteritis

Gut

Volumn 65, Issue 8, 2016, Pages 1279-1288

  Wouters, Mira M ^a   Van Wanrooy, Sander ^a   Nguyen, Anh ^b,c   Dooley, James ^b,c   Aguilera Lizarraga, Javier ^a   Van Brabant, Winde ^a   Garcia Perez, Josselyn E ^b,c   Van Oudenhove, Lukas ^a   Van Ranst, Marc ^a   Verhaegen, Jan ^a   Liston, Adrian ^b,c   Boeckxstaens, Guy ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

IGE; IRRITABLE BOWEL SYNDROME

Indexed keywords

DRINKING WATER; INTERLEUKIN 2; TAP WATER; CYTOKINE;

ADULT; AGE; ANXIETY; ARTICLE; B LYMPHOCYTE; CAMPYLOBACTER JEJUNI; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; COMORBIDITY; DEPRESSION; DYSPEPSIA; EPIDEMIC; FEMALE; FOLLOW UP; GASTROENTERITIS; GIARDIA INTESTINALIS; HUMAN; INFECTIOUS GASTROENTERITIS; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NOROVIRUS; POSTINFECTIOUS IRRITABLE BOWEL SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM BIOPSY; SOMATIZATION; BELGIUM; BIOPSY; CAMPYLOBACTER INFECTIONS; CLINICAL TRIAL; COMPLICATION; DISEASE PREDISPOSITION; GIARDIASIS; IMMUNOLOGY; IRRITABLE BOWEL SYNDROME; ISOLATION AND PURIFICATION; MENTAL STRESS; MICROBIOLOGY; MIDDLE AGED; OUTCOME ASSESSMENT; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; QUESTIONNAIRE; RECTUM; RISK FACTOR;

ADULT; BELGIUM; BIOPSY; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; COMORBIDITY; CYTOKINES; DISEASE OUTBREAKS; DISEASE SUSCEPTIBILITY; DRINKING WATER; FEMALE; GASTROENTERITIS; GIARDIA LAMBLIA; GIARDIASIS; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHIATRIC STATUS RATING SCALES; RECTUM; RISK FACTORS; STRESS, PSYCHOLOGICAL; SURVEYS AND QUESTIONNAIRES;

EID: 84931470552     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2015-309460     Document Type: Article

References (40)

1. Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47:804-11.
2. Dunlop SP, Jenkins D, Neal KR, et al. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003;125:1651-9.
3. Mearin F, Perez-Oliveras M, Perello A, et al. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 2005;129:98-104.
4. McKendrick MW, Read NW. Irritable bowel syndrome-post salmonella infection. J Infect 1994;29:1-3.
5. Porter CK, Faix DJ, Shiau D, et al. Postinfectious gastrointestinal disorders following norovirus outbreaks. Clin Infect Dis 2012;55:915-22.
6. Zanini B, Ricci C, Bandera F, et al. Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak. Am J Gastroenterol 2012;107:891-9.
7. Wensaas KA, Langeland N, Hanevik K, et al. Irritable bowel syndrome and chronic fatigue 3 years after acute giardiasis: historic cohort study. Gut 2012;61:214-9.
8. Thabane M, Kottachchi DT, Marshall JK. Systematic review and meta-Analysis: The incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2007;26:535-44.
9. Marshall JK, Thabane M, Garg AX, et al. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology 2006;131:445-50.
10. Marshall JK, Thabane M, Garg AX, et al. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut 2010;59:605-11.
11. Ford AC, Talley NJ. Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: A systematic review. J Gastroenterol 2011;46:421-31.
12. Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999;44:400-6.
13. Gwee KA, Collins SM, Read NW, et al. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut 2003;52:523-6.
14. Mearin F, Perello A, Balboa A, et al. Pathogenic mechanisms of postinfectious functional gastrointestinal disorders: results 3 years after gastroenteritis. Scand J Gastroenterol 2009;44:1173-85.
15. Spiller RC. Role of infection in irritable bowel syndrome. J Gastroenterol 2007;42 (Suppl 17):41-7.
16. Neal KR, Barker L, Spiller RC. Prognosis in post-infective irritable bowel syndrome: A six year follow up study. Gut 2002;51:410-3.
17. Chiappelli F, Manfrini E, Franceschi C, et al. Brain corticosteroid receptors: studies on the mechanism, function, and neurotoxicity of corticosteroid action. Proceedings of a conference. Arlington, Virginia, March 2-5, 1994. Ann N Y Acad Sci 1994;746:1-499.
18. Dragos D, Tanasescu MD. The effect of stress on the defense systems. J Med Life 2010;3:10-18.
19. Yang PC, Jury J, Soderholm JD, et al. Chronic psychological stress in rats induces intestinal sensitization to luminal antigens. Am J Pathol 2006;168:104-14.
20. Shaashua L, Sominsky L, Levi B, et al. In vivo suppression of plasma IL-12 levels by acute and chronic stress paradigms: potential mediating mechanisms and sex differences. Brain Behav Immun 2012;26:996-1005.
21. Jin J, Wang X, Wang Q et al. Chronic psychological stress induces the accumulation of myeloid-derived suppressor cells in mice. PLoS ONE 2013;8:e74497.
22. Hu D, Wan L, Chen M, et al. Essential role of IL-10/STAT3 in chronic stress-induced immune suppression. Brain Behav Immun 2014;36:118-27.
23. Sharma R, Kapila R, Dass G, et al. Improvement in Th1/Th2 immune homeostasis, antioxidative status and resistance to pathogenic E. coli on consumption of probiotic Lactobacillus rhamnosus fermented milk in aging mice. Age (Dordr) 2014;36:9686.
24. Braeye T, DE Schrijver K, Wollants E, et al. A large community outbreak of gastroenteritis associated with consumption of drinking water contaminated by river water, Belgium, 2010. Epidemiol Infect 2015;143:711-19.
25. Spiller RC, Humes DJ, Campbell E, et al. The patient health questionnaire 12 somatic symptom scale as a predictor of symptom severity and consulting behaviour in patients with irritable bowel syndrome and symptomatic diverticular disease. Aliment Pharmacol Ther 2010;32:811-20.
26. von SF, Tornieporth N, Waiyaki P, et al. Risk and aetiology of diarrhoea at various tourist destinations. Lancet 2000;356:133-4.
27. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.
28. Bjelland I, Dahl AA, Haug TT, et al. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res 2002;52:69-77.
29. Amado IF, Berges J, Luther RJ, et al. IL-2 coordinates IL-2-producing and regulatory T cell interplay. J Exp Med 2013;210:2707-20.
30. Hughes PA, Zola H, Penttila IA, et al. Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms? Am J Gastroenterol 2013;108:1066-74.
31. Liebregts T, Adam B, Bredack C, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007;132:913-20.
32. Grover M, Camilleri M, Smith K, et al. On the fiftieth anniversary. Postinfectious irritable bowel syndrome: mechanisms related to pathogens. Neurogastroenterol Motil 2014;26:156-67.
33. Dunlop SP, Jenkins D, Spiller RC. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol 2003;98:1578-83.
34. Nicholl BI, Halder SL, Macfarlane GJ, et al. Psychosocial risk markers for new onset irritable bowel syndrome-results of a large prospective population-based study. Pain 2008;137:147-55.
35. Lee KJ, Kim YB, Kim JH, et al. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. J Gastroenterol Hepatol 2008;23:1689-94.
36. Balemans D, Alpizar YA, Nasser Y, et al. Evidence for histamine-mediated sensitization of TRPV1 signaling in sensory neurons in mice and IBS patients. Gastroenterology 2014;146:S220-S221 Abstract Sa1178.
37. Vicario M, Gonzalez-Castro AM, Martinez C, et al. Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations. Gut 2015;64:1379-88.
38. Ohman L, Lindmark AC, Isaksson S, et al. B-cell activation in patients with irritable bowel syndrome (IBS). Neurogastroenterol Motil 2009;21:644-50, e27.
39. McKernan DP, Gaszner G, Quigley EM, et al. Altered peripheral toll-like receptor responses in the irritable bowel syndrome. Aliment Pharmacol Ther 2011;33:1045-52.
40. Scully P, McKernan DP, Keohane J, et al. Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity. Am J Gastroenterol 2010;105:2235-43.